Results
News
In the latest effort to quantify the burden of expensive medicines, a new study found that the cost of two widely used hepatitis C treatments remains out of reach for people in many poor countries and poses a “financial and ethical dilemma” for payers and doctors. The study found that if a patient paid for treatment out of pocket, the cost of a full course of Sovaldi alone would equal one year or more of average earnings for people in 12 countries.
Hepatitis C drugs remain unaffordable in many countries, says WHO studyNews
Uber and Sidian Bank announced today that they have partnered to launch an innovative Uber Vehicle Solutions Programme that will give driver-partners and business investors convenient and affordable access to the quality vehicles they need to start or grow their Uber-based businesses. This comes shortly after Uber celebrated 1 million rides taken in Kenya since its launch just 15 months ago.
Uber Kenya and Sidian Bank Launch $100M Vehicle Solutions ProgrammeBlog Post
Opportunity International, a pioneer in the microfinance space, operates 39 microfinance institutions in Africa, Eastern Europe, Central and East Asia and Latin America. But recently, the organization has been undergoing a strategic shift, announcing the sale of several MFIs in sub-Saharan Africa. We spoke with Opportunity's CEO, Vicki Escarra, about these moves – and many other topics – in this Q&A, NextBillion's second podcast.
Opportunity International’s Evolving Microfinance Strategy: A Podcast Q&A with CEO Vicki EscarraNews
With the future of global health more uncertain than it has been in more than a decade, the first hats have been tossed into the election ring for top leadership at the World Health Organization. It is a dire time for WHO, which has seen its financial and political support erode steadily for the last decade, its credibility suffering mightily over its slow and sloppy response to the 2014 Ebola outbreak.
Viewpoint: Secret Vote on WHO Bodes Ill for Future of Global HealthNews
Six companies, including some from Rwanda, have expressed interest in setting up a plant to produce medicated mosquito bed nets to be distributed in the country, a senior official in the Ministry of Trade and Industry (MINICOM) has said.
Rwanda to Produce Mosquito Bed NetsNews
The revenue growth opportunity in vaccines looks far more promising when compared to the overall market for pharmaceuticals. Revenues earned by vaccines manufacturers worldwide reached $27.6 billion in 2015 according to Kalorama Information, up 11% from $24.7 billion in 2014, as sales in all segments expanded (Figure 1). This is, by Kalorama’s estimate, at least five to ten times the revenue growth rate of the overall pharmaceutical market in recent years. The world vaccines market is predicted to increase at a compound annual rate of 7.6% during 2013–2022, reaching $45.1 billion in 2022 as new product introductions continue and usage of current products expands further.
For Struggling Pharma Market, Vaccines Offer Path to RevenueNews
Dramatic gains in life expectancy have been made globally since 2000, but major inequalities persist within and among countries, according to this year’s “World Health Statistics: Monitoring Health for the SDGs”.
Life Expectancy Increased by 5 Years Since 2000, but Health Inequalities PersistNews
EcoCash and MTN Zambia officially unveiled a remittance partnership that will enable MTN customers in Zimbabwe’s northern neighbor to send money into the country via the mobile platform MTN Money Wallet.
MTN & EcoCash launch sub-Saharan Africa’s first operator-to-operator cross-border remittance channel
